Bufalin enhanced temozolomide efficacy by promoting EGFR protein degradation in glioblastoma
{{output}}
Background: Glioblastoma (GBM), the most aggressive form of glioma, is associated with a poor patient prognosis. Temozolomide (TMZ), the first-line chemotherapeutic agent for GBM patients, has its efficacy closely tied to patient... ...
